The Yin and Yang of nicotine: Harmful during development, beneficial in adult patient populations

Frontiers in Pharmacology

Volumn 3 OCT, Issue , 2012, Pages

  Counotte, Danielle S ^a   Smit, August B ^b   Spijker, Sabine ^b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

ADHD; Animal model; Brain development; Developmental stages; Nicotine

Indexed keywords

ISPRONICLINE; NICOTINE;

ADOLESCENT HEALTH; ARTICLE; ATTENTION; ATTENTION DEFICIT DISORDER; BRAIN DEVELOPMENT; DEVELOPMENTAL STAGE; DISEASE ASSOCIATION; EXPERIMENTAL ANIMAL; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; IMPULSIVENESS; MATERNAL SMOKING; MENTAL TASK; NERVE CELL NETWORK; NONHUMAN; PRENATAL EXPOSURE; RISK FACTOR; TASK PERFORMANCE;

EID: 84870727934     PISSN: None     EISSN: 16639812     Source Type: Journal    
DOI: 10.3389/fphar.2012.00180     Document Type: Article

References (76)

1. Arria, A. M., Derauf, C., Lagasse, L. L., Grant, P., Shah, R., Smith, L., et al. (2006). Methamphetamine and other substance use during pregnancy: preliminary estimates from the Infant Development, Environment,and Lifestyle (IDEAL) study. Matern. Child Health J. 10, 293-302.
2. Baker, R. R., Massey, E. D., and Smith, G. (2004). An overview of the effects of tobacco ingredients on smoke chemistry and toxicity. Food Chem. Toxicol. 42(Suppl.), S53-S83.
3. Bickel, W. K., Odum, A. L., and Madden, G. J. (1999). Impulsivity and cigarette smoking: delay discounting in current, never, and exsmokers. Psychopharmacology (Berl.) 146, 447-454.
4. Biederman, J., Monuteaux, M. C., Faraone, S. V., and Mick, E. (2009). Parsing the associations between prenatal exposure to nicotine and offspring psychopathology in a nonreferred sample. J. Adolesc. Health 45, 142-148.
5. Bordia, T., Campos, C., Huang, L., and Quik, M. (2008). Continuous and intermittent nicotine treatment reduces L-3,4-dihydroxyphenylalanine (L-DOPA)-induced dyskinesias in a rat model of Parkinson's disease. J. Pharmacol. Exp. Ther. 327, 239-247.
6. Brasic, J. R., Cascella, N., Kumar, A., Zhou, Y., Hilton, J., Raymont, V., et al. (2012). Positron emission tomography experience with 2-[(1)(8)F]fluoro-3-(2(S)azetidinylmethoxy)pyridine (2-[(1)(8)F]FA) in the living human brain of smokers with paranoid schizophrenia. Synapse 66, 352-368
7. Counotte et al. Beneficial and harmful effects of nicotine on attention before, during, and after pregnancy. MMWR Morb. Mortal.Wkly. Rep. 58, 1-29.
8. Chassin, L., Presson, C. C., Rose, J. S., and Sherman, S. J. (1996). The natural history of cigarette smoking from adolescence to adulthood: demographic predictors of continuity and change. Health Psychol. 15, 478-484.
9. Cornelius, M. D., and Day, N. L. (2009). Developmental consequences of prenatal tobacco exposure. Curr. Opin. Neurol. 22, 121-125.
10. Counotte, D. S., Goriounova, N. A., Li, K. W., Loos, M., Van Der Schors, R. C., Schetters, D., et al. (2011a). Lasting synaptic changes underlie attention deficits caused by nicotine exposure during adolescence. Nat. Neurosci. 14, 417-419.
11. Counotte, D. S., Smit, A. B., Pattij, T., and Spijker, S. (2011b). Development of the motivational system during adolescence, and its sensitivity to disruption by nicotine. Dev. Cogn. Neurosci. 1, 430-443.
12. Counotte,D. S.,Spijker,S.,Van De Burgwal, L. H., Hogenboom, F., Schoffelmeer, A. N., De Vries, T. J., et al. (2009). Long-lasting cognitive deficits resulting from adolescent nicotine exposure in rats. Neuropsychopharmacology 34, 299-306.
13. Dietz, P. M., Homa, D., England, L. J., Burley, K., Tong, V. T., Dube, S. R., et al. (2010). Estimates of nondisclosure of cigarette smoking among pregnant and nonpregnant women of reproductive age in the United States. Am. J. Epidemiol. 173, 355-359.
14. Dunbar, G., Boeijinga, P. H., Demazieres,A., Cisterni, C., Kuchibhatla, R., Wesnes, K., et al. (2007). Effects of TC-1734 (AZD3480), a selective neuronal nicotinic receptor agonist, on cognitive performance and the EEG of young healthy male volunteers. Psychopharmacology (Berl.) 191, 919-929.
15. Dunbar, G. C., Kuchibhatla, R. V., and Lee, G. (2011). A randomized double-blind study comparing 25 and 50 mg TC-1734 (AZD3480) with placebo, in older subjects with age-associated memory impairment. J. Psychopharmacol. (Oxford) 25, 1020-1029.
16. Dwyer,J. B.,McQuown,S. C.,and Leslie, F. M. (2009). The dynamic effects of nicotine on the developing brain. Pharmacol. Ther. 122, 125-139.
17. Echeverria, V., Zeitlin, R., Burgess, S., Patel, S., Barman, A., Thakur, G., et al. (2010). Cotinine reduces amyloid-beta aggregation and improves memory in Alzheimer's disease mice. J. Alzheimers Dis. 24, 817-835.
18. Einarson, A., and Riordan, S. (2009). Smoking in pregnancy and lactation: a review of risks and cessation strategies. Eur. J. Clin. Pharmacol. 65, 325-330.
19. Endo, T., Maekawa, F., Voikar, V., Haijima, A., Uemura, Y., Zhang, Y., et al. (2011). Automated test of behavioral flexibility in mice using a behavioral sequencing task in IntelliCage. Behav. Brain Res. 221, 172-181.
20. England, L., and Zhang, J. (2007). Smoking and risk of preeclampsia: a systematic review. Front. Biosci. 12, 2471-2483.
21. Ernst, M., Heishman, S. J., Spurgeon, L., and London, E. D. (2001a). Smoking history and nicotine effects on cognitive performance. Neuropsychopharmacology 25, 313-319.
22. Ernst, M., Moolchan, E. T., and Robinson, M. L. (2001b). Behavioral and neural consequences of prenatal exposure to nicotine. J. Am. Acad. Child Adolesc. Psychiatry 40, 630-641.
23. Espy,K. A.,Fang,H.,Johnson,C.,Stopp, C., and Wiebe, S. A. (2011). Prenatal tobacco exposure: developmental outcomes in the neonatal period. Dev. Psychol. 47, 153-156.
24. Foulds, J., Stapleton, J., Swettenham, J., Bell, N., McSorley, K., and Russell, M. A. (1996). Cognitive performance effects of subcutaneous nicotine in smokers and never-smokers. Psychopharmacology (Berl.) 127, 31-38.
25. Frolich, L., Ashwood, T., Nilsson, J., and Eckerwall, G. (2011). Effects of AZD3480 on cognition in patients with mild-to-moderate Alzheimer's disease: a phase IIb dose-finding study. J. Alzheimers Dis. 24, 363-374.
26. Galera, C., Cote, S. M., Bouvard, M. P., Pingault, J. B., Melchior, M., Michel, G., et al. (2011). Early risk factors for hyperactivity-impulsivity and inattention trajectories from age 17 months to 8 years. Arch. Gen. Psychiatry 68, 1267-1275.
27. Goriounova, N. A., and Mansvelder, H. D. (2012). Nicotine exposure during adolescence leads to shortand long-term changes in spike timingdependent plasticity in rat prefrontal cortex. J. Neurosci. 32, 10484-10493.
28. Jacobsen, L. K., Krystal, J. H., Mencl, W. E., Westerveld, M., Frost, S. J., and Pugh, K. R. (2005). Effects of smoking and smoking abstinence on cognition in adolescent tobacco smokers. Biol. Psychiatry 57, 56-66.
29. Jacobsen, L. K., Slotkin, T. A., Mencl, W. E.,Frost,S. J.,and Pugh, K. R. (2007) Gender-specific effects of prenatal and adolescent exposure to tobacco smoke on auditory and visual attention. Neuropsychopharmacology 32, 2453-2464.
30. Kadir, A., Almkvist, O., Wall, A., Langstrom, B., and Nordberg, A. (2006). PET imaging of cortical 11Cnicotine binding correlates with the cognitive function of attention in Alzheimer's disease. Psychopharmacology (Berl.) 188, 509-520.
31. Kleykamp, B. A., Jennings, J. M., and Eissenberg, T. (2011). Effects of transdermal nicotine and concurrent smoking on cognitive performance in tobacco-abstinent smokers. Exp. Clin. Psychopharmacol. 19, 75-84.
32. Lambert, N. M., and Hartsough, C. S. (1998). Prospective study of tobacco smoking and substance dependencies among samples of ADHD and non-ADHD participants. J. Learn. Disabil. 31, 533-544.
33. Lasser, K., Boyd, J. W., Woolhandler, S., Himmelstein, D. U., McCormick, D., and Bor, D. H. (2000). Smoking and mental illness: a populationbased prevalence study. JAMA 284, 2606-2610.
34. Lawrence, N. S., Ross, T. J., and Stein, E. A. (2002). Cognitive mechanisms of nicotine on visual attention. Neuron 36, 539-548.
35. Le Houezec, J., Halliday, R., Benowitz, N. L., Callaway, E., Naylor, H., and Herzig, K. (1994). A low dose of subcutaneous nicotine improves information processing in non-smokers. Psychopharmacology (Berl.) 114, 628-634.
36. Lerman, C., Audrain, J., Tercyak, K., Hawk, L. W. Jr., Bush, A., Crystal-Mansour, S., et al. (2001). Attention-Deficit Hyperactivity Disorder (ADHD) symptoms and smoking patterns among participants in a smoking-cessation program. Nicotine Tob. Res. 3, 353-359.
37. Levin, E. D., Conners, C. K., Silva, D., Hinton, S. C., Meck, W. H., March, J., et al. (1998). Transdermal nicotine effects on attention. Psychopharmacology (Berl.) 140, 135-141.
38. Levin, E. D., Kaplan, S., and Boardman, A. (1997). Acute nicotine interactions with nicotinic and muscarinic antagonists: working and reference memory effects in the 16-arm radial maze. Behav. Pharmacol. 8, 236-242.
39. McClernon, F. J., Kollins, S. H., Lutz, A. M., Fitzgerald, D. P., Murray, D. W., Redman, C., et al. (2008). Effects of smoking abstinence on adult smokers with and without attention deficit hyperactivity disorder: results of a preliminary study. Psychopharmacology (Berl.) 197, 95-105.
40. Michalon,A.,Sidorov,M.,Ballard,T.M., Ozmen, L., Spooren, W., Wettstein, J. G., et al. (2012). Chronic pharmacological mGlu5 inhibition corrects fragile X in adult mice. Neuron 74, 49-56.
41. Milberger, S., Biederman, J., Faraone, S. V., Chen, L., and Jones, J. (1996). Is maternal smoking during pregnancy a risk factor for attention deficit hyperactivity disorder in children? Am. J. Psychiatry 153, 1138-1142.
42. Mitchell, M. R., Mendez, I. A., Vokes, C. M., Damborsky, J. C., WinzerSerhan, U. H., and Setlow, B. (2012). Effects of developmental nicotine exposure in rats on decision-making in adulthood. Behav. Pharmacol. 23, 34-42.
43. Mitchell, S. H. (1999). Measures of impulsivity in cigarette smokers and non-smokers. Psychopharmacology (Berl.) 146, 455-464.
44. Motlagh, M. G., Sukhodolsky, D. G., Landeros-Weisenberger, A., Katsovich, L., Thompson, N., Scahill, L., et al. (2011). Adverse effects of heavy prenatal maternal smoking on attentional control in children with ADHD. J. Atten. Disord. 15,593-603.
45. Musso, F., Bettermann, F.,Vucurevic, G., Stoeter, P., Konrad, A., and Winterer, G. (2007). Smoking impacts on prefrontal attentional network function in young adult brains. Psychopharmacology (Berl.) 191, 159-169.
46. Newhouse,P.A.,Potter,A.,and Singh,A. (2004). Effects of nicotinic stimulation on cognitive performance. Curr. Opin. Pharmacol. 4, 36-46.
47. Newhouse, P. A., Potter, A. S., Dumas, J. A., and Thiel, C. M. (2011). Functional brain imaging of nicotinic effects on higher cognitive processes. Biochem. Pharmacol. 82, 943-951.
48. Novick, L. F. (2000). Smoking is the leading preventable cause of death and disability in the United States. J. Public Health Manag. Pract. 6, vi.
49. Obinu, M. C., Reibaud, M., Miquet, J. M., Pasquet, M., and Rooney, T. (2002). Brain-selective stimulation of nicotinic receptors by TC-1734 enhances ACh transmission from frontoparietal cortex and memory in rodents. Prog. Neuropsychopharmacol. Biol. Psychiatry 26, 913-918.
50. Pediatrics, A. A. O. (2000).Clinicalpractice guideline: diagnosis and evaluation of the child with attentiondeficit/hyperactivity disorder. Pediatrics 105, 1158-1170.
51. Poorthuis, R. B., Goriounova, N. A., Couey, J. J., and Mansvelder, H. D. Counotte et al. Beneficial and harmful effects of nicotine on attention (2009). Nicotinic actions on neuronal networks for cognition: general principles and long-term consequences. Biochem. Pharmacol. 78, 668-676.
52. Rezvani, A. H., Cauley, M. C., Johnson, E. C., Gatto, G. J., and Levin, E. D. (2012). Effects of AZD3480, a neuronal nicotinic acetylcholine receptor agonist, and donepezil on dizocilpine-induced attentional impairment in rats. Psychopharmacology (Berl.) 223, 251-258.
53. Sacco, K. A., Bannon, K. L., and George, T. P. (2004). Nicotinic receptor mechanisms and cognition in normal states and neuropsychiatric disorders. J. Psychopharmacol. (Oxford) 18, 457-474.
54. Sagiv, S. K., Epstein, J. N., Bellinger, D. C., and Korrick, S. A. (2012). Preand postnatal risk factors for ADHD in a nonclinical pediatric population. J. Atten. Disord. PMID: 22298092. [Epub ahead of print].
55. Sastry, B. V., Chance, M. B., Hemontolor, M. E., and Goddijn-Wessel, T. A. (1998). Formation and retention of cotinine during placental transfer of nicotine in human placental cotyledon. Pharmacology 57, 104-116.
56. Schmitz, M., Denardin, D., Laufer Silva, T., Pianca, T., Hutz, M. H., Faraone, S., et al. (2006). Smoking during pregnancy and attention-deficit/hyperactivity disorder, predominantly inattentive type: a case-control study. J. Am. Acad. Child Adolesc. Psychiatry 45, 1338-1345.
57. Schneider, T., Bizarro, L., Asherson, P. J., and Stolerman, I. P. (2012). Hyperactivity, increased nicotine consumption and impaired performance in the five-choice serial reaction time task in adolescent rats prenatally exposed to nicotine. Psychopharmacology (Berl.) PMID: 22562524. [Epub ahead of print].
58. Schneider, T., Ilott, N., Brolese, G., Bizarro, L., Asherson, P. J., and Stolerman, I. P. (2011). Prenatal exposure to nicotine impairs performance of the 5-choice serial reaction time task in adult rats. Neuropsychopharmacology 36, 1114-1125.
59. Services and U. S. Department of Health and Human Services. (2010). How Tobacco Smoke Causes Disease: The Biology and Behavioral Basis for SmokingAttributable Disease. A Report of the Surgeon General. Available at: http://www.surgeongeneral.gov/library/reports/tobaccosmoke/full_report.pdf
60. Shimohama, S. (2009). Nicotinic receptor-mediated neuroprotection in neurodegenerative disease models. Biol. Pharm. Bull. 32, 332-336.
61. Skinner, M. D., Aubin, H. J., and Berlin, I. (2004). Impulsivity in smoking, nonsmoking, and ex-smoking alcoholics. Addict. Behav. 29, 973-978.
62. Slotkin, T. A. (2008). If nicotine is a developmental neurotoxicant in animal studies, dare we recommend nicotine replacement therapy in pregnant women and adolescents? Neurotoxicol. Teratol. 30, 1-19.
63. Slotkin, T. A., Epps, T. A., Stenger, M. L., Sawyer, K. J., and Seidler, F. J. (1999). Cholinergic receptors in heart and brainstem of rats exposed to nicotine during development: implications for hypoxia tolerance and perinatal mortality. Brain Res. Dev. Brain Res. 113, 1-12.
64. Slotkin, T. A., Ryde, I. T., and Seidler, F. J. (2007). Separate or sequential exposure to nicotine prenatally and in adulthood: persistent effects on acetylcholine systems in rat brain regions. Brain Res. Bull. 74, 91-103.
65. Slotkin, T. A., Seidler, F. J., and Spindel, E. R. (2010). Prenatal nicotine exposure in rhesus monkeys compromises development of brainstem and cardiac monoamine pathways involved in perinatal adaptation and sudden infant death syndrome:amelioration by vitamin C. Neurotoxicol. Teratol. 33, 431-434.
66. Spinella, M. (2002). Correlations between orbitofrontal dysfunction and tobacco smoking. Addict. Biol. 7, 381-384.
67. Thapar, A., Fowler, T., Rice, F., Scourfield, J., Van Den Bree, M., Thomas, H., et al. (2003). Maternal smoking during pregnancy and attention deficit hyperactivity disorder symptoms in offspring. Am. J. Psychiatry 160, 1985-1989.
68. Thapar, A., Rice, F., Hay, D., Boivin, J., Langley, K., Van Den Bree, M., et al. (2009). Prenatal smoking might not cause attention-deficit/hyperactivity disorder: evidence from a novel design. Biol. Psychiatry 66, 722-727.
69. Trueman, R. C., Dunnett, S. B., Jones, L., and Brooks, S. P. (2012). Five choice serial reaction time performance in the Hdh(Q92) mouse model of Huntington's disease. Brain Res.Bull. 88, 163-170.
70. Velligan, D., Brenner, R., Sicuro, F., Walling, D., Riesenberg, R., Sfera, A., et al. (2012). Assessment of the effects of AZD3480 on cognitive function in patients with schizophrenia. Schizophr. Res. 134, 59-64.
71. Vossel, S., Warbrick, T., Mobascher, A., Winterer, G., and Fink, G. R. (2011). Spatial and sustained attention in relation to smoking status: behavioural performance and brain activation patterns. J. Psychopharmacol. (Oxford) 25, 1485-1495.
72. West, R., and Hack, S. (1991). Effect of cigarettes on memory search and subjective ratings. Pharmacol. Biochem. Behav. 38, 281-286.
73. Wignall, N. D., and de Wit, H. (2011). Effects of nicotine on attention and inhibitory control in healthy nonsmokers. Exp. Clin. Psychopharmacol. 19, 183-191.
74. Wikstrom, A. K., Stephansson, O., and Cnattingius, S. (2010). Tobacco use during pregnancy and preeclampsia risk: effects of cigarette smoking and snuff. Hypertension 55, 1254-1259.
75. Winter,Y., and Schaefers,A. T. (2011). A sorting system with automated gates permits individual operant experiments with mice from a social home cage. J. Neurosci. Methods 196, 276-280.
76. Winzer-Serhan, U. H. (2008). Longterm consequences of maternal smoking and developmental chronic nicotine exposure. Front. Biosci. 13, 636-649.